A detailed history of Covestor LTD transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Covestor LTD holds 10 shares of IOVA stock, worth $72. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10
Previous 20 50.0%
Holding current value
$72
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$7.59 - $17.47 $75 - $174
-10 Reduced 50.0%
10 $0
Q4 2023

Feb 09, 2024

SELL
$3.3 - $8.89 $9 - $26
-3 Reduced 13.04%
20 $0
Q3 2023

Nov 13, 2023

SELL
$4.44 - $8.79 $13 - $26
-3 Reduced 11.54%
23 $0
Q2 2023

Aug 11, 2023

BUY
$5.36 - $9.06 $58 - $99
11 Added 73.33%
26 $0
Q4 2022

Feb 13, 2023

SELL
$5.62 - $10.0 $5 - $10
-1 Reduced 6.25%
15 $0
Q3 2022

Nov 14, 2022

SELL
$9.53 - $13.11 $66 - $91
-7 Reduced 30.43%
16 $0
Q2 2022

Aug 10, 2022

SELL
$6.38 - $18.33 $89 - $256
-14 Reduced 37.84%
23 $0
Q1 2022

May 13, 2022

BUY
$12.38 - $19.1 $37 - $57
3 Added 8.82%
37 $1,000
Q4 2021

Feb 10, 2022

BUY
$16.55 - $27.63 $562 - $939
34 New
34 $1,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.15B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.